Get the Stockscreener App
7.573
0.50%
0.033
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $7.573, with a volume of 2.01M.
It is up +0.50% in the last 24 hours and down -16.73% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$7.54
Open:
$7.67
24h Volume:
2.01M
Relative Volume:
0.16
Market Cap:
$8.95B
Revenue:
$15.05B
Net Income/Loss:
$-883.30M
P/E Ratio:
-10.23
EPS:
-0.74
Net Cash Flow:
$1.89B
1W Performance:
-0.42%
1M Performance:
-16.73%
6M Performance:
-33.47%
1Y Performance:
-33.12%
1-Day Range:
$7.42
$7.68
1-Week Range:
$6.85
$7.99
52-Week Range:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
7.575 | 8.95B | 15.05B | -883.30M | 1.89B | -0.74 |
|
ZTS
Zoetis Inc
|
150.91 | 67.16B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.10 | 45.20B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.28 | 44.98B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.55 | 15.33B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.00 | 12.70B | 2.76B | 1.11B | 898.10M | 22.77 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Viatris names Hemanth J. Varghese as Chief Strategy Officer - Investing.com
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein - GlobeNewswire
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer - Viatris
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Viatris Inc. - Bluefield Daily Telegraph
Strategic Powerhouse: Viatris Taps 20-Year Healthcare Expert to Lead Growth Vision - Stock Titan
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS - TradingView
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
VTRS STOCK REMINDER: The Viatris Inc. Class Action Deadline - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming DeadlinesVTRS | FinancialContent - FinancialContent
VTRS INVESTOR NOTICE: Viatris, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
VIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc.VTRS - The Malaysian Reserve
Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost - GlobeNewswire
Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10 - Insider Monkey
VTRS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Viatris Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
VTRS STOCK FRAUD: Did Viatris Inc. Commit Securities Fraud? - GlobeNewswire
VTRS STOCK FRAUD: Did Viatris Inc. Commit Securities Fraud? Investors are Notified to Contact BFA Law by the June 3 Court Deadline (NASDAQ:VTRS) - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. LawsuitVTRS - PR Newswire
Shareholders that lost money on Viatris Inc.(VTRS) should contact Levi & Korsinsky about pending Class ActionVTRS - ACCESS Newswire
VIATRIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been ... - Eagle-Tribune
VIATRIS ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Viatris Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your RightsVTRS - ACCESS Newswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Viatris - GlobeNewswire
Class Action Filed Against Viatris Inc. (VTRS) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Viatris Inc. (VTRS)June 3, 2025 Deadline to Join – Contact Levi ... - Eagle-Tribune
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc.VTRS - GlobeNewswire
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - MarketScreener
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - Morningstar
The Gross Law Firm Reminds Viatris Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025VTRS - MarketScreener
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Viatris Inc. (VTRS) Shareholders - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Viatris Inc. (VTRS) Investors to Inquire About Securities Fraud Class Action - Business Wire
Deadline Approaching: Viatris Inc. (VTRS) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith - Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - GlobeNewswire
VTRS CLASS NOTICE: A Class Action was Filed on behalf of - GlobeNewswire
Viatris Puts Pen To Paper On $335m Opioid Settlement Agreement - insights.citeline.com
Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire
Investors in Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your RightsVTRS - ACCESS Newswire
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Viatris, Inc. (VTRS) - TradingView
VTRS FRAUD NOTICE: Viatris Inc. Investors with Losses may have been Affected by Fraud; Contact BFA Law by June 3 Court Deadline - ACCESS Newswire
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
Viatris to Pay $335 Million for Settlement of Opioid-Related Claims - Yahoo Finance
VTRS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Viatris Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS) - Morningstar
Law Offices of Howard G. Smith Encourages Viatris Inc. (VTRS) Investors To Inquire About Securities Fraud Class Action - Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - Business Wire
VTRS BREAKING NEWS: Viatris Inc. Stock Plummets 15% - GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. - GlobeNewswire
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):